Aminoguanidine

DRUG4 trials

Sponsors

Imperial College London, Radboud University Medical Center, University of Minnesota

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseDiabetic RetinopathyEndotoxemia

Phase 1

Effect of Selective iNOS Inhibition During Human Endotoxemia

CompletedNCT00184990

Radboud University Medical CenterEndotoxemia

Start: 2005-01-31End: 2005-09-30Updated: 2008-04-15

Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients

CompletedNCT02099981

University of MinnesotaDiabetic Retinopathy

Start: 2016-07-31End: 2017-12-31Updated: 2018-01-18

Unknown Phase

Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects

CompletedNCT00159380

Imperial College LondonAsthma

Start: 2003-09-30End: 2005-03-31Updated: 2019-07-10

NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD

CompletedNCT00180635

Imperial College LondonChronic Obstructive Pulmonary Disease

Start: 2003-10-31End: 2006-07-31Updated: 2019-07-10

Related Papers

Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients.

2008-08-2141 citations